Domain adaptation from clinical trials data to the tertiary care clinic - Application to ALS

Ben Hadad, Boaz Lerner

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

1 Scopus citations

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating and incurable disease affecting motor neurons, leading to progressive paralysis and death on average within three to five years from onset. The disease is characterized by highly variable patterns and rates of progression, which pose challenges to developing reliable and accurate ALS disease state prediction models to be used on a daily basis in clinics with little data. To meet these challenges, we suggest domain adaptation from a large, but unfortunately biased, clinical trials database to that of a tertiary care ALS clinic. To evaluate the reliability and accuracy of the suggested paradigm, we examine a naïve approach by which training is based only on the clinical trials data compared with a domain adaptation approach of an initial training using this same data followed by fine-tuning training using the clinic data. We also allow summarization of the clinical longitudinal data to evaluate non-temporal models, e.g., random forest (RF), XGBoost (XGB), and multilayer perceptron (MLP), partially exploiting the dynamic information hidden in patient clinical records, in comparison to the long short-term memory (LSTM) recurrent neural network, fully exploiting the temporal information in the data. First, we notice the XGB outperformance in terms of the ALS disease state prediction error to the RF and MLP, but surprisingly also to the LSTM regardless of prediction time (up to 24 months ahead). We contribute the inferiority of the highly parametrized neural network to the impact of the curse of dimensionality. Second, we show that this error does not significantly increase when the model is trained using only the clinical trials data, especially for LSTM in long prediction times. Finally, we demonstrate that fine-tuning of the clinical trials-based pre-trained model using the clinic data improves the LSTM and MLP performance compared to using solely the clinical trials or clinic data.

Original languageEnglish
Title of host publicationProceedings - 19th IEEE International Conference on Machine Learning and Applications, ICMLA 2020
EditorsM. Arif Wani, Feng Luo, Xiaolin Li, Dejing Dou, Francesco Bonchi
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages539-544
Number of pages6
ISBN (Electronic)9781728184708
DOIs
StatePublished - 1 Dec 2020
Event19th IEEE International Conference on Machine Learning and Applications, ICMLA 2020 - Virtual, Miami, United States
Duration: 14 Dec 202017 Dec 2020

Conference

Conference19th IEEE International Conference on Machine Learning and Applications, ICMLA 2020
Country/TerritoryUnited States
CityVirtual, Miami
Period14/12/2017/12/20

Keywords

  • Amyotrophic lateral sclerosis (ALS)
  • LSTM
  • clinical trials data
  • disease-state prediction
  • domain adaptation

ASJC Scopus subject areas

  • Artificial Intelligence
  • Computer Science Applications
  • Computer Vision and Pattern Recognition
  • Hardware and Architecture

Fingerprint

Dive into the research topics of 'Domain adaptation from clinical trials data to the tertiary care clinic - Application to ALS'. Together they form a unique fingerprint.

Cite this